Cognitive Performance Concomitant With Vision Acuity Predicts 13-Year Risk for Mortality

Objective: To assess the joint impact of cognitive performance and visual acuity on mortality over 13-year follow-up in a representative US sample.Methods: Data from National Health and Nutrition Examination Survey (NHANES) participants (≥18 years old) were linked with the death record data of the N...

Full description

Bibliographic Details
Main Authors: Huan Liao, Zhuoting Zhu, Hongxuan Wang, Xiaoming Rong, Charlotte Aimee Young, Ying Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2019.00065/full
_version_ 1818111100717105152
author Huan Liao
Huan Liao
Zhuoting Zhu
Hongxuan Wang
Hongxuan Wang
Xiaoming Rong
Xiaoming Rong
Charlotte Aimee Young
Ying Peng
Ying Peng
author_facet Huan Liao
Huan Liao
Zhuoting Zhu
Hongxuan Wang
Hongxuan Wang
Xiaoming Rong
Xiaoming Rong
Charlotte Aimee Young
Ying Peng
Ying Peng
author_sort Huan Liao
collection DOAJ
description Objective: To assess the joint impact of cognitive performance and visual acuity on mortality over 13-year follow-up in a representative US sample.Methods: Data from National Health and Nutrition Examination Survey (NHANES) participants (≥18 years old) were linked with the death record data of the National Death Index (NDI) with mortality follow-up through December 31, 2011. Cognitive performance was evaluated by the Digit Symbol Substitution Test (DSST) and cognitive performance impairment was defined as the DSST score equal to or less than the median value in the study population. Visual impairment (VI) was defined as presenting visual acuity worse than 20/40 in the better-seeing eye. Risks of all-cause and specific-cause mortality were estimated with Cox proportional hazards models after adjusting for confounders.Results: A total of 2,550 participants 60 years and older from two waves of (NHANES, 1999–2000, 2001–2002) were included in the current analysis. Over a median follow-up period of 9.92 years, 952 (35.2%) died of all causes, of whom 239 (23.1%), 224 (24.0%), and 489 (52.9%) died from cardiovascular disease (CVD), cancer, and non-CVD/non-cancer mortality, respectively. Cognitive performance impairment and VI increased the odds for mortality. Co-presence of VI among cognitive impaired elderly persons predicted nearly a threefold increased risk of all-cause mortality [hazard ratios (HRs), 2.74; 95% confidence interval (CI), 2.02–3.70; P < 0.001) and almost a fourfold higher risk of non-CVD/non-cancer mortality (HR, 3.72; 95% CI, 2.30–6.00; P < 0.001) compared to having neither impairment.Conclusion: People aged 60 years and over with poorer cognitive performance were at higher risk of long-term mortality, and were especially vulnerable to further mortality when concomitant with VI. It is informative for clinical implication in terms of early preventive interventions.
first_indexed 2024-12-11T02:57:41Z
format Article
id doaj.art-f163b0f84ab5408ba1333bdaa781819d
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-11T02:57:41Z
publishDate 2019-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-f163b0f84ab5408ba1333bdaa781819d2022-12-22T01:23:07ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652019-03-011110.3389/fnagi.2019.00065430627Cognitive Performance Concomitant With Vision Acuity Predicts 13-Year Risk for MortalityHuan Liao0Huan Liao1Zhuoting Zhu2Hongxuan Wang3Hongxuan Wang4Xiaoming Rong5Xiaoming Rong6Charlotte Aimee Young7Ying Peng8Ying Peng9Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Ophthalmology, University of California, San Francisco, San Francisco, CA, United StatesDepartment of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaObjective: To assess the joint impact of cognitive performance and visual acuity on mortality over 13-year follow-up in a representative US sample.Methods: Data from National Health and Nutrition Examination Survey (NHANES) participants (≥18 years old) were linked with the death record data of the National Death Index (NDI) with mortality follow-up through December 31, 2011. Cognitive performance was evaluated by the Digit Symbol Substitution Test (DSST) and cognitive performance impairment was defined as the DSST score equal to or less than the median value in the study population. Visual impairment (VI) was defined as presenting visual acuity worse than 20/40 in the better-seeing eye. Risks of all-cause and specific-cause mortality were estimated with Cox proportional hazards models after adjusting for confounders.Results: A total of 2,550 participants 60 years and older from two waves of (NHANES, 1999–2000, 2001–2002) were included in the current analysis. Over a median follow-up period of 9.92 years, 952 (35.2%) died of all causes, of whom 239 (23.1%), 224 (24.0%), and 489 (52.9%) died from cardiovascular disease (CVD), cancer, and non-CVD/non-cancer mortality, respectively. Cognitive performance impairment and VI increased the odds for mortality. Co-presence of VI among cognitive impaired elderly persons predicted nearly a threefold increased risk of all-cause mortality [hazard ratios (HRs), 2.74; 95% confidence interval (CI), 2.02–3.70; P < 0.001) and almost a fourfold higher risk of non-CVD/non-cancer mortality (HR, 3.72; 95% CI, 2.30–6.00; P < 0.001) compared to having neither impairment.Conclusion: People aged 60 years and over with poorer cognitive performance were at higher risk of long-term mortality, and were especially vulnerable to further mortality when concomitant with VI. It is informative for clinical implication in terms of early preventive interventions.https://www.frontiersin.org/article/10.3389/fnagi.2019.00065/fullcognitive performancevision acuityjoint impactmortalityNHANES
spellingShingle Huan Liao
Huan Liao
Zhuoting Zhu
Hongxuan Wang
Hongxuan Wang
Xiaoming Rong
Xiaoming Rong
Charlotte Aimee Young
Ying Peng
Ying Peng
Cognitive Performance Concomitant With Vision Acuity Predicts 13-Year Risk for Mortality
Frontiers in Aging Neuroscience
cognitive performance
vision acuity
joint impact
mortality
NHANES
title Cognitive Performance Concomitant With Vision Acuity Predicts 13-Year Risk for Mortality
title_full Cognitive Performance Concomitant With Vision Acuity Predicts 13-Year Risk for Mortality
title_fullStr Cognitive Performance Concomitant With Vision Acuity Predicts 13-Year Risk for Mortality
title_full_unstemmed Cognitive Performance Concomitant With Vision Acuity Predicts 13-Year Risk for Mortality
title_short Cognitive Performance Concomitant With Vision Acuity Predicts 13-Year Risk for Mortality
title_sort cognitive performance concomitant with vision acuity predicts 13 year risk for mortality
topic cognitive performance
vision acuity
joint impact
mortality
NHANES
url https://www.frontiersin.org/article/10.3389/fnagi.2019.00065/full
work_keys_str_mv AT huanliao cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality
AT huanliao cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality
AT zhuotingzhu cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality
AT hongxuanwang cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality
AT hongxuanwang cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality
AT xiaomingrong cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality
AT xiaomingrong cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality
AT charlotteaimeeyoung cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality
AT yingpeng cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality
AT yingpeng cognitiveperformanceconcomitantwithvisionacuitypredicts13yearriskformortality